Canopy Growth Corp: Will it Ever Be a Buy?

Canopy Growth Corp (TSX:WEED) keeps going lower. Will it ever find a bottom?

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

Canopy Growth Corp (TSX:WEED) has been the limbo bar of stocks: when you think it can’t go lower, it goes lower still. Technically, the stock is currently up from its post-legalization low of $0.50, set back in July. However, it’s still down 99% from the highs set just before legalization.

The question has to be asked:

Will this stock ever be a buy?

WEED stock is currently inexpensive by some measures. For example, it has a price/book ratio of exactly one, which is low by the standards of today’s market. However, the company keeps losing money and spending its cash pile, which means the “book value” in the denominator of the aforementioned price/book ratio is shrinking. It’s only natural for a value investor to feel tempted by a stock that’s flirting with all-time lows, but nevertheless, red flags remain. In this article, I will explore the question of whether Canopy Growth Corp stock will ever be a buy.

Revenue declining

In its most recent quarter, Canopy Growth Corp managed to eke out slightly positive revenue growth of 2.5%. This was a good showing for Canopy, as its revenue has mostly been declining lately. In the trailing 12-month period, the company’s revenue declined 12.8%. Over the last three years, its revenue declined by 8.3% CAGR. Revenue is still up by an impressive 31.5% CAGR over the last five years, but remember that five years ago, the stock went for $42. Overall, the recent story of Canopy Growth Corp is one of persistent decline.

Persistent losses

Another thing that Canopy has been very persistent about over the last few years is losing money. In its most recent quarter, it lost $31 million. In the prior-year quarter, it lost a full $2 billion! Granted, the loss witnessed in the previous quarter was much improved from a year before. But still, it was significant. Back in 2018, Canopy got a $5 billion investment from Constellation Brands, a U.S. beverage company. Today, the cash pile that came from that deal is down to $533 million. So, Canopy’s losses have not just been on paper accounting losses. The company has been genuinely bleeding cash.

This all has bearing on WEED’s valuation. The stock is optically cheap, with low price/sales and price/book ratios. However, sales and book value are both declining. If Canopy keeps burning cash at the rate it has been since the 2018 Constellation Brands investment, it will eventually have no book value to speak of. Should that occur, the stock will not look to have been cheap at today’s prices.

The final verdict

Having reviewed the pertinent valuation and financial performance metrics, I’m prepared to deliver a verdict on whether Canopy Growth Corp stock will ever be a buy.

First things first, I do not consider it a buy now. We’ll need to see at least another quarter’s earnings before we can be sure the cash burn and book value disappearance can be mitigated.

As for whether the stock can ever be a buy, well, it’s possible. If the company cuts costs enough it may someday become profitable. However, cannabis is a commodity, one with lots of suppliers. I wouldn’t touch stocks in this industry until after a few big name producers go out of business. Then and only then will cannabis be interesting.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »